Baloxavir in Combination With Oseltamivir in Allogenic Bone Marrow Transplant Recipients With Influenza

NCT05170009 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Slow enrollment rate

Conditions

Influenza

Interventions

DRUG: Baloxavir Marboxil
DRUG: Placebo
DRUG: Oseltamivir

Sponsor

Weill Medical College of Cornell University

Collaborators

[object Object]